J.P. Morgan – 2024 Medtech Industry Insights: Investment Trends, M&A

The report by J.P. Morgan "2024 Medtech Industry Insights: Investment Trends, M&A" examines the shifts in the medtech sector's investment and acquisition landscape. In 2024, the medtech sector experienced a notable shift with fewer but larger funding rounds, resulting in a total investment of $19.1 billion across 691 rounds. Mergers and acquisitions surged, reaching levels close to the 2021 peak, with 305 acquisitions totaling $63.1 billion. IPO activity showed a gradual recovery with four medtech IPOs raising $744.5 million. Licensing partnerships moved towards more conservative deal structures, with 1,051 deals valued at $7.2 billion. The report highlights J.P. Morgan's commitment to supporting clients through strong relationships, substantial capital investments, and a skilled team of specialists in life sciences and healthcare.